deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01193998

Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

Analysis of the Impact of Using a Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

Sponsor: Roche Pharma AG

Updated 6 times since 2017 Last updated: Jun 12, 2014 Started: Sep 30, 2010 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Heart Failure and Dyspnea, this trial is completed. The trial is conducted by Roche Pharma AG and has accumulated 6 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotCompleted~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Oct 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Oct 2021 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Roche Pharma AG
  • Unity Health Toronto
Data source: Unity Health Toronto

For direct contact, visit the study record on ClinicalTrials.gov .